NCT00915473View on ClinicalTrials.gov

Greater Occipital Nerve Block for Migraine Prophylaxis

PHASE4CompletedINTERVENTIONAL

Enrollment

70

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions

Migraine Headache

Interventions

DRUG

bupivicaine

2.5 mL 0.5% bupivicaine

DRUG

normal saline

2.75 mL normal saline

DRUG

methylprednisolone

0.5 mL 20 mg methylprednisolone

DRUG

lidocaine

0.25 mL 1% lidocaine

Trial Locations (1)

85054

Mayo Clinic, Phoenix

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

National Center for Advancing Translational Sciences (NCATS)

NIH

lead

Mayo Clinic

OTHER